1. Home
  2. GEL vs IOVA Comparison

GEL vs IOVA Comparison

Compare GEL & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genesis Energy L.P.

GEL

Genesis Energy L.P.

HOLD

Current Price

$16.38

Market Cap

2.0B

Sector

Energy

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.45

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEL
IOVA
Founded
1996
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
GEL
IOVA
Price
$16.38
$3.45
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$19.50
$9.00
AVG Volume (30 Days)
278.9K
13.8M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
4.19%
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
$2,912,770,000.00
N/A
Revenue This Year
$12.12
$47.74
Revenue Next Year
N/A
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
43.60
N/A
52 Week Low
$14.55
$1.67
52 Week High
$18.64
$5.63

Technical Indicators

Market Signals
Indicator
GEL
IOVA
Relative Strength Index (RSI) 44.88 46.22
Support Level $16.28 $3.23
Resistance Level $16.42 $4.27
Average True Range (ATR) 0.47 0.26
MACD 0.00 -0.02
Stochastic Oscillator 47.03 20.11

Price Performance

Historical Comparison
GEL
IOVA

About GEL Genesis Energy L.P.

Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: